medline.ch Onkologie

	Impact of Staged Rehabilitation Training on Urinary Incontinence Recovery After Radical Prostatectomy: A Retrospective Analysis. Am J Mens Health Hu Y, Yao L, Liu C, Tian J, Liu A. PMID: 42141375 [PubMed - indexed for MEDLINE]
	CD19/BCMA-Targeted Chimeric Antigen Receptor-T Cell Therapy for Anti-HLA Antibody Sensitisation in Patients With Acute Leukaemia: A Pilot Clinical Study. HLA Zheng H, Zhao H, Zhu X, Feng J, Wei G, Han S, Huang S, Cui J, Fu S, Zhang M, Zhang Y, Shi J, Luo Y, Chang AH, Hu Y, Huang H. PMID: 42141373 [PubMed - indexed for MEDLINE]
	Baseline self-efficacy and engagement in a symptom management intervention after cancer treatment: an exploratory analysis of a sequentialÂ multipleÂ assignment randomizedÂ trial. J Cancer Surviv Hadeed MC, Segrin C, Sikorskii A, Garcia DO, Bea J, Badger TA. PMID: 42141337 [PubMed - as supplied by publisher]
	MRI- and report-based multimodal model with SHAP-based explanation for preoperative prediction of deep stromal invasion in early-stage cervical cancer. Insights Imaging Xie R, Ai Y, Bao A, Xie L, Wang W, Zhu K, Wu J, Wu Y, Xiong R, Jin X. PMID: 42141332 [PubMed]
	Bridging the gap: a systematic literature review and meta-analysis on the management of rectal wall defect after transanal excision. Tech Coloproctol Vaghiri S, Gorgun E, Kessler H, Knoefel WT, Prassas D. PMID: 42141324 [PubMed - indexed for MEDLINE]
	The ATP-adenosine axis as a driver of tumor-associated macrophage reprogramming in colorectal cancer: mechanistic insights into immune evasion and therapeutic vulnerabilities. Purinergic Signal Albukhari AF. PMID: 42141299 [PubMed - indexed for MEDLINE]
	Timing of adjuvant chemoradiotherapy after resection and survival in glioblastoma: a single-centre cohort analysis. J Neurooncol Palumbo C, De Schlichting E, Le Lann F, Leboucher A, Habert-Dantigny R, Gay E, Chabardes S, Grand S, Boutonnat J, Pasteris C, Pavillet J, Kallel M, Lazard A. PMID: 42141297 [PubMed - indexed for MEDLINE]
	Early, delayed, or combined contrast-enhanced mammography for detecting residual disease after neoadjuvant chemotherapy in breast cancer. Eur Radiol Bellini C, Bicchierai G, Maiello C, Amato F, de Benedetto D, di Naro F, Vidali S, Tonelli P, Vanzi E, Boeri C, Visani L, Vezzosi V, Orzalesi L, Susini T, Miele V, Nori J. PMID: 42141291 [PubMed - as supplied by publisher]
	Integrated single-cell and bulk transcriptomic analyses unveil a necroptosis-related prognostic model and its association with tumor microenvironment remodeling in gastric cancer. Discov Oncol Li Y, Pan W, Ying X, Yan X, Hu S. PMID: 42141239 [PubMed - as supplied by publisher]
	Tuberculosis infection in BCG vaccinated children and adolescents with rheumatological diseases treated by tumor necrosis factor-Î± inhibitors. Eur J Pediatr Ademhan Tural D, Do, Özsezen B, Karaman A, Sunman B, Nayir Büyük, Güzelka, Albo, Erdal MA, Emiralio, Bilginer Y, Yalç, Özçelik U, Özen S, Kiper N. PMID: 42141213 [PubMed - indexed for MEDLINE]
	Head and neck squamous cell carcinoma: current and emerging therapeutic strategies. Clin Transl Oncol Ahuja P, Kadian L, Goyal S, Yadav R. PMID: 42141200 [PubMed - as supplied by publisher]
	Short-term outcomes of bridge-to-surgery using self-expanding metallic stents in robotic colorectal surgery for obstructive left-sided colorectal cancer: a consecutive cohort study. Surg Endosc Fujimoto Y, Honboh T, Sakisaka S, Izumi T, Yoshida R, Mizutani T, Harada N, Sadanaga N, Yoshizumi T. PMID: 42141184 [PubMed - as supplied by publisher]
	Study on the synergistic efficacy and mechanism of CD24 silencing combined with trastuzumab in HER2-positive breast cancer. J Mol Histol Lu Y, Zhou X, Gao Y, Zhu Z, Deng B, Lv W, Fu Z, Ding H, Zhong L. PMID: 42141178 [PubMed - indexed for MEDLINE]
	Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study. Nat Cancer Jayaram A, Rashid M, Reid AHM, Orlando F, Thakali S, Zakka L, Goncalves M, O'Dwyer J, Alifrangis C, Jones R, Pintus E, Needleman S, Bianchini D, Wingate A, Ng K, Linch M, McGovern U, Staffurth J, Crabb SJ, Brock S, Birtle A, Vainauskas O, Leone G, Chiwewe M, Hackshaw A, Lopes A, Wetterskog D, Demichelis F, Attard G. PMID: 42141175 [PubMed - as supplied by publisher]
	A Phase I trial of the anti-IL23 monoclonal antibody tildrakizumab, in combination with abiraterone acetate, for the treatment of metastatic castration-resistant prostate cancer. Invest New Drugs Chandran K, Guo C, Pacey S, Villacampa G, Matthews R, Prout T, Fernandes J, Turner A, Parmar M, Riisnaes R, Ferreira A, Carreira S, Bertan C, Crespo M, Figueiredo I, Yuan W, Bogdan D, Raynaud F, Ruddle R, Calì B, Maddalena M, Calcinotto A, Yap C, Sharp A, Alimonti A, De Bono J, Paschalis A. PMID: 42141162 [PubMed - as supplied by publisher]
	Feasibility study of the Four-Session Cognitive-Behavioral Therapy-based Psychological Intervention Program for women with HER2-positive metastatic breast cancer. Support Care Cancer Szekeres T, Balázs MÁ, Madarász B, Póti Z, Urbán R, Dank M, Vizin G. PMID: 42141145 [PubMed - indexed for MEDLINE]
	Effects of activity pacing-related interventions on cancer-related fatigue and classification of behavior change techniques: A systematic review and meta-analysis. Support Care Cancer Shimizu Y, Tsuji K, Hanai A, Hosokawa M. PMID: 42141128 [PubMed - indexed for MEDLINE]
	Expert recommendations for PIK3CA testing in HR+/HER2- locally advanced and metastatic breast cancer. NPJ Breast Cancer Marchiò C, Rojo F, Copson ER, Schmitt F, Bellosillo B, Fremd C. PMID: 42140989 [PubMed - as supplied by publisher]
	Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial. Nat Commun Garrido-Castro AC, Graham N, Li KX, Bi L, Crowdis J, Bi K, Park J, Pastorello R, Li Y, Gupta H, Kuntz T, Petry R, Pasquina LW, Patel A, Lange P, DiLullo M, Attaya V, Frey AM, Childress MA, Wesolowski R, Sinclair N, Sinclair S, Lo S, Tung N, Faggen M, Kaufman PA, Block CC, Walsh J, Toke M, Chen W, Wucherpfennig KW, Tian Y, Williams AJ, Mukhopadhyay S, Dasgupta T, Schnitt S, Cherniack AD, Barroso R, Ligibel J, Lin NU, Mittendorf EA, Tayob N, Van Allen E, Tolaney SM. PMID: 42140950 [PubMed - as supplied by publisher]
	Sequencing PARP inhibitors in breast cancer: lessons learned and emerging insights. NPJ Breast Cancer Aloss K, Frederick MI, Hassan S. PMID: 42140928 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 1935261

Seite 1 von 96764

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung